TrademarkDir
HLS THERAPEUTICS
DEAD

Serial Number

86515140

Owner

HLS THERAPEUTICS, INC.

Attorney

Megan K. Bowen

Filing Date

Jan 27, 2015

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

HLS THERAPEUTICS Trademark

Serial Number: 86515140 • Registration: 5796674

HLS THERAPEUTICS is a trademark filed by HLS THERAPEUTICS, INC. on January 27, 2015. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

HLS THERAPEUTICS, INC.

Ste 2600, 3 Bentall Ctr, 595 Burrard St
Vancover V7x1L3 , CA

Entity Type: 03

Trademark Details

Filing Date

January 27, 2015

Registration Date

July 9, 2019

Published for Opposition

August 21, 2018

Cancellation Date

January 23, 2026

Goods & Services

Pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes, cardiovascular disorders, central nervous system (CNS) disorders, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, neurological diseases, namely, Alzheimer's, Huntington's Disease, cerebral palsy, neurological disorders, namely, brain injury, spinal cord injury, seizure disorders, dermatological disorders, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, respiratory, gastrointestinal and other metabolic disorders, namely, diabetes, hypoglycemia, gout, osteoarthritis, muscular dystrophy, anemia, bulimia nervosa, anorexia, obesity and hypothyroidism, osteoporosis and other bone disorders, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, immunomodulatory diseases, namely, autoimmune diseases, immunologic deficiency syndromes; and antidepressants, antivirals, antibacterial pharmaceuticals, antifungal preparations, anti-inflammatories, analgesics and other pain therapeutics, namely, pain relief medications in the nature of muscle relaxants, anti-anxiety and anti-convulsion medications and acetaminophen, pharmaceutical preparations to treat diseases of the genitourinary system in women, hormones, namely, progesterone, progestins, and estrogens, hormone receptor modulators, and osteoporosis medicines

Pharmaceutical drug formulation development; clinical evaluation and testing in the nature of conducting clinical trials relating to pharmaceuticals

Filing History

CANCELLED SEC. 8 (6-YR)
Jan 23, 2026 C8..
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Sep 10, 2025 ASCK
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jul 9, 2024 REM1
REGISTERED-PRINCIPAL REGISTER
Jul 9, 2019 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Jun 4, 2019 DP1B
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 4, 2019 AITU
NOTICE OF ALLOWANCE CANCELLED
May 20, 2019 IUCN
TEAS POST PUBLICATION AMENDMENT RECEIVED
May 20, 2019 EPPA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 13, 2019 EXRA
SOU EXTENSION 1 GRANTED
Apr 11, 2019 EX1G
SOU EXTENSION 1 FILED
Apr 11, 2019 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 11, 2019 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 16, 2018 NOAM
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Sep 12, 2018 ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Aug 22, 2018 ASCK
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 21, 2018 NPUB
PUBLISHED FOR OPPOSITION
Aug 21, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 1, 2018 NONP
ELECTRONIC RECORD REVIEW COMPLETE
Jul 16, 2018 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Jul 13, 2018 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 9, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 9, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 9, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 9, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 9, 2018 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 24, 2018 GNRN
NON-FINAL ACTION E-MAILED
Jan 24, 2018 GNRT
NON-FINAL ACTION WRITTEN
Jan 24, 2018 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 2, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 2, 2018 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Dec 18, 2017 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jun 19, 2017 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jun 19, 2017 GNSI
SUSPENSION INQUIRY WRITTEN
Jun 19, 2017 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jun 19, 2017 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 16, 2016 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 16, 2016 GNSL
SUSPENSION LETTER WRITTEN
Dec 16, 2016 CNSL
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jun 24, 2016 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jun 24, 2016 GNSI
SUSPENSION INQUIRY WRITTEN
Jun 24, 2016 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jun 23, 2016 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 22, 2015 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 22, 2015 GNSL
SUSPENSION LETTER WRITTEN
Dec 22, 2015 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 1, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 1, 2015 CRFA
ASSIGNED TO LIE
Nov 30, 2015 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 6, 2015 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 12, 2015 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 12, 2015 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 7, 2015 GNRN
NON-FINAL ACTION E-MAILED
May 7, 2015 GNRT
NON-FINAL ACTION WRITTEN
May 7, 2015 CNRT
ASSIGNED TO EXAMINER
May 1, 2015 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 5, 2015 NWOS
NEW APPLICATION ENTERED
Jan 30, 2015 NWAP

Related Trademarks